CADDI Workshop | Smart Drug Development & Design




Click here to register for this event

Date: March 12, 2019

Location: Egan Research Center | Raytheon Amphitheater 360 Huntington Ave Boston, MA 02115  

This one-of-a-kind symposium will focus on key considerations for transitioning a molecule from discovery to clinic including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of patient focus design principles. The agenda is designed to be highly interactive with activities designed for the audience to work in teams to apply the principles from the presentations and ample time for networking.

Agenda:

8:00 am – 8:30 am WELCOME & INTRODUCTION
Prof. Rebecca Carrier, Professor and Associate Chair for Research, Chemical Engineering, Northeastern University
Dr. Cornell Stamoran, Founder, Catalent Institute

8:30 am – 9:05 am IMPORTANCE OF API CHARACTERIZATION FOR IMPROVING DEVELOPABILITY OF SMALL MOLECULES
 Dr. Chris Towler, Senior Fellow, Novartis Institutes for BioMedical Research

9:05 am – 9:40 am MODELING THE PHARMACOKINETIC CHALLENGES OF ORAL SMALL MOLECULE DRUGS
Dr. Katarina Vulic, Senior Scientist, Novartis Institutes for BioMedical Research

9:40 am – 9:50 am BREAK

9:50 am – 10:30 am FORMULATION STRATEGIES TO OVERCOME ORAL BIOAVAILABILITY CHALLENGES OF SMALL MOLECULE DRUGS
Mr. Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions

10:30 am – 11:05 am MECHANISTIC STUDIES AND MODELING TO PREDICT THE IMPACT OF LIPIDS ON ORAL ABSORPTION
Prof. Rebecca Carrier, Northeastern University

11:05 am – 12:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 1 AM SPEAKERS

12:00 pm – 1:00 pm NETWORKING LUNCH & MEET THE EXPERTS

1:00 pm – 1:35 am CMC AND QUALITY CONSIDERATIONS

1:35 pm – 2:10 pm INSIGHTS AND STRATEGIES TO INCORPORATE PATIENT FOCUSED DESIGN
 Dr. Cornell Stamoran, Founder, Catalent Institute

2:10 pm – 2:45 pm STRATEGIES FOR PROGRESSING TO PHASE I FORMULATIONS TO IMPROVE YOUR SPEED TO AND SUCCESS IN THE CLINIC
Dr. Manuel Sanchez-Felix, Senior Fellow, Novartis Institute for Biomedical Research

2:45 pm – 3:00 pm BREAK

3:00 pm – 4:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 2 PM SPEAKERS  CONCLUDING REMARKS
Dr. Ronak Savla, Scientific Affairs Manager, Catalent Pharma Solutions